- AU$11.23bn
- AU$12.78bn
- AU$3.00bn
- 96
- 23
- 99
- 84
Annual income statement for ALS, fiscal year end - March 31st, AUD millions except per share, conversion factor applied.
2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,761 | 1,952 | 2,279 | 2,462 | 2,999 |
| Cost of Revenue | |||||
| Gross Profit | 1,579 | 1,727 | 2,027 | 2,195 | 2,694 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,473 | 1,633 | 1,843 | 2,283 | 2,554 |
| Operating Profit | 289 | 319 | 436 | 178 | 445 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 249 | 280 | 391 | 121 | 363 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 174 | 192 | 276 | 15 | 259 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 173 | 191 | 291 | 12.9 | 256 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 173 | 191 | 291 | 12.9 | 256 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.319 | 0.505 | 0.616 | 0.422 | 0.578 |
| Dividends per Share |